ATARA BIOTHERAPEUTICS, INC. Additional Paid in Capital, Common Stock
ATARA BIOTHERAPEUTICS, INC. (ATRA) had Additional Paid in Capital, Common Stock of $1.99 billion as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2026-08-12
- 2026-06-30: Additional Paid in Capital, Common Stock $1.99B.
- 2026-03-31: Additional Paid in Capital, Common Stock $1.99B.
- 2025-12-31: Additional Paid in Capital, Common Stock $1.98B.
- 2025-09-30: Additional Paid in Capital, Common Stock $1.98B.
| Period end | Additional Paid in Capital, Common Stock | Additional Paid in Capital, Common Stock as first filed |
|---|---|---|
| 2026-06-30 | $1.99B 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $1.99B 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $1.98B 10-Q · filed 2026-08-12 | |
| 2025-09-30 | $1.98B 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $1.98B 10-Q · filed 2025-08-11 | |
| 2025-03-31 | $1.96B 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $1.96B 10-K · filed 2026-03-16 | |
| 2024-09-30 | $1.95B 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $1.91B 10-Q · filed 2024-08-12 | |
| 2024-03-31 | $1.90B 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $1.87B 10-K · filed 2025-03-07 | $1.87B 10-K · filed 2024-03-28 |
| 2023-09-30 | $1.86B 10-Q · filed 2023-11-01 | |
| 2023-06-30 | $1.85B 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $1.83B 10-Q · filed 2023-05-08 | |
| 2022-12-31 | $1.82B 10-K · filed 2024-03-28 | |
| 2022-09-30 | $1.81B 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $1.79B 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $1.78B 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $1.74B 10-K · filed 2023-02-08 | |
| 2021-09-30 | $1.68B 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $1.62B 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $1.60B 10-Q · filed 2021-05-04 | |
| 2020-12-31 | $1.59B 10-K · filed 2022-02-28 | |
| 2020-09-30 | $1.40B 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $1.35B 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $1.14B 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $1.11B 10-K · filed 2021-03-01 | |
| 2019-09-30 | $1.06B 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $899.67M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $877.13M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $866.54M 10-K · filed 2020-02-27 | |
| 2018-09-30 | $850.84M 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $841.98M 10-Q · filed 2018-08-01 | |
| 2018-03-31 | $777.80M 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $474.66M 10-K · filed 2019-02-26 | |
| 2017-09-30 | $467.38M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $451.50M 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $436.10M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $431.07M 10-K · filed 2018-02-27 | |
| 2016-09-30 | $429.09M 10-Q · filed 2016-11-04 | |
| 2016-06-30 | $423.60M 10-Q · filed 2016-08-08 | |
| 2016-03-31 | $418.45M 10-Q · filed 2016-05-06 | |
| 2015-12-31 | $413.73M 10-K · filed 2017-03-09 | |
| 2015-09-30 | $410.56M 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $214.31M 10-Q · filed 2015-08-07 | |
| 2015-03-31 | $216.16M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $144.17M 10-K · filed 2016-03-04 | |
| 2014-10-31 | $74.60M 10-K · filed 2015-02-26 | |
| 2013-12-31 | $2.20M 10-K · filed 2015-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |